---
figid: PMC7160552__OR-43-06-1737-g01
figlink: pmc/articles/PMC7160552/figure/f2-or-43-06-1737/
number: Figure 2
caption: Schematic diagram that introduces in detail the molecular mechanisms, clinical
  values and cell phenotypes affected by HOXA11-AS in different tumor types, including
  (A) NSCLC, (B) HCC, (C) glioma, (D) CC, and (E) BC. ‘Upregulation’/‘downregulation’
  indicates that the expression level of HOXA11-AS in such a tumor was increased/decreased
  compared with normal tissues. The gray arrows (‘bind’/‘sponge’) indicate that HOXA11-AS
  binds to the promoter region of a gene or, as a sponge, binds to a miRNA. The black
  arrows (‘Inf’) indicate that HOXA11-AS affects the phenotypes and the clinical characteristics
  of the cancer under consideration. The blue (‘Pro’)/green (‘In’) arrows indicate
  the promoting or inhibitory effects on the downstream genes, respectively. The purple
  arrows (‘Reg’) indicate the regulatory effects on the downstream pathway. NSCLC,
  non-small cell lung cancer; HCC, hepatocellular carcinoma; CRC, colorectal cancer;
  BC, breast cancer; HOXA11-AS, HOXA11 antisense RNA.
pmcid: PMC7160552
papertitle: Recent advances in unraveling the molecular mechanisms and functions of
  HOXA11-AS in human cancers and other diseases.
reftext: Cheng Wei, et al. Oncol Rep. 2020 Jun;43(6):1737-1754.
pmc_ranked_result_index: '21678'
pathway_score: 0.8164762
filename: OR-43-06-1737-g01.jpg
figtitle: Schematic diagram that introduces in detail the molecular mechanisms, clinical
  values and cell phenotypes affected by HOXA11-AS in different tumor types, including
  (A) NSCLC, (B) HCC, (C) glioma, (D) CC, and (E) BC
year: '2020'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7160552__OR-43-06-1737-g01.html
  '@type': Dataset
  description: Schematic diagram that introduces in detail the molecular mechanisms,
    clinical values and cell phenotypes affected by HOXA11-AS in different tumor types,
    including (A) NSCLC, (B) HCC, (C) glioma, (D) CC, and (E) BC. ‘Upregulation’/‘downregulation’
    indicates that the expression level of HOXA11-AS in such a tumor was increased/decreased
    compared with normal tissues. The gray arrows (‘bind’/‘sponge’) indicate that
    HOXA11-AS binds to the promoter region of a gene or, as a sponge, binds to a miRNA.
    The black arrows (‘Inf’) indicate that HOXA11-AS affects the phenotypes and the
    clinical characteristics of the cancer under consideration. The blue (‘Pro’)/green
    (‘In’) arrows indicate the promoting or inhibitory effects on the downstream genes,
    respectively. The purple arrows (‘Reg’) indicate the regulatory effects on the
    downstream pathway. NSCLC, non-small cell lung cancer; HCC, hepatocellular carcinoma;
    CRC, colorectal cancer; BC, breast cancer; HOXA11-AS, HOXA11 antisense RNA.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PDE4D
  - GIF
  - TGFB1
  - TGFB2
  - TGFB3
  - SGPL1
  - STAT3
  - TENM1
  - FAM126A
  - CDK4
  - CDK2
  - LATS1
  - DUSP5
  - CDKN2A
  - EZH2
  - CDH1
  - PADI2
  - CEACAM5
  - cisplatin
  - Non-small-cell lung cancer
  - NSCLC
  - tumor
  - Hepatocellular carcinoma
  - Glioma
  - Colorectal cancer
  - Breast cancer
genes:
- word: PDE4D
  symbol: PDE4D
  source: hgnc_symbol
  hgnc_symbol: PDE4D
  entrez: '5144'
- word: Inf
  symbol: INF
  source: hgnc_alias_symbol
  hgnc_symbol: GIF
  entrez: '2694'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB1
  entrez: '7040'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB2
  entrez: '7042'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB3
  entrez: '7043'
- word: Inf
  symbol: INF
  source: hgnc_alias_symbol
  hgnc_symbol: GIF
  entrez: '2694'
- word: SPI
  symbol: SPL
  source: hgnc_alias_symbol
  hgnc_symbol: SGPL1
  entrez: '8879'
- word: Stat3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: Inf
  symbol: INF
  source: hgnc_alias_symbol
  hgnc_symbol: GIF
  entrez: '2694'
- word: Inf
  symbol: INF
  source: hgnc_alias_symbol
  hgnc_symbol: GIF
  entrez: '2694'
- word: Inf
  symbol: INF
  source: hgnc_alias_symbol
  hgnc_symbol: GIF
  entrez: '2694'
- word: TNM
  symbol: TNM
  source: hgnc_prev_symbol
  hgnc_symbol: TENM1
  entrez: '10178'
- word: (HCC)
  symbol: HCC
  source: hgnc_alias_symbol
  hgnc_symbol: FAM126A
  entrez: '84668'
- word: CDK4
  symbol: CDK4
  source: hgnc_symbol
  hgnc_symbol: CDK4
  entrez: '1019'
- word: InCyclinD1,CDK4
  symbol: CDK4
  source: hgnc_symbol
  hgnc_symbol: CDK4
  entrez: '1019'
- word: CDK2
  symbol: CDK2
  source: hgnc_symbol
  hgnc_symbol: CDK2
  entrez: '1017'
- word: CyclinE,CDK2
  symbol: CDK2
  source: hgnc_symbol
  hgnc_symbol: CDK2
  entrez: '1017'
- word: LATS1
  symbol: LATS1
  source: hgnc_symbol
  hgnc_symbol: LATS1
  entrez: '9113'
- word: DUSP5
  symbol: DUSP5
  source: hgnc_symbol
  hgnc_symbol: DUSP5
  entrez: '1847'
- word: Inf
  symbol: INF
  source: hgnc_alias_symbol
  hgnc_symbol: GIF
  entrez: '2694'
- word: p16,
  symbol: p16
  source: hgnc_alias_symbol
  hgnc_symbol: CDKN2A
  entrez: '1029'
- word: Inf
  symbol: INF
  source: hgnc_alias_symbol
  hgnc_symbol: GIF
  entrez: '2694'
- word: DUSP5
  symbol: DUSP5
  source: hgnc_symbol
  hgnc_symbol: DUSP5
  entrez: '1847'
- word: Inf
  symbol: INF
  source: hgnc_alias_symbol
  hgnc_symbol: GIF
  entrez: '2694'
- word: EZH2
  symbol: EZH2
  source: hgnc_symbol
  hgnc_symbol: EZH2
  entrez: '2146'
- word: LATS1
  symbol: LATS1
  source: hgnc_symbol
  hgnc_symbol: LATS1
  entrez: '9113'
- word: Inf
  symbol: INF
  source: hgnc_alias_symbol
  hgnc_symbol: GIF
  entrez: '2694'
- word: Inf
  symbol: INF
  source: hgnc_alias_symbol
  hgnc_symbol: GIF
  entrez: '2694'
- word: Inf
  symbol: INF
  source: hgnc_alias_symbol
  hgnc_symbol: GIF
  entrez: '2694'
- word: Inf
  symbol: INF
  source: hgnc_alias_symbol
  hgnc_symbol: GIF
  entrez: '2694'
- word: Inf
  symbol: INF
  source: hgnc_alias_symbol
  hgnc_symbol: GIF
  entrez: '2694'
- word: Inf
  symbol: INF
  source: hgnc_alias_symbol
  hgnc_symbol: GIF
  entrez: '2694'
- word: Inf
  symbol: INF
  source: hgnc_alias_symbol
  hgnc_symbol: GIF
  entrez: '2694'
- word: E-cadherin
  symbol: CDH1
  source: hgnc_symbol
  hgnc_symbol: CDH1
  entrez: '999'
- word: PADI2
  symbol: PADI2
  source: hgnc_symbol
  hgnc_symbol: PADI2
  entrez: '11240'
- word: TNM
  symbol: TNM
  source: hgnc_prev_symbol
  hgnc_symbol: TENM1
  entrez: '10178'
- word: Inf
  symbol: INF
  source: hgnc_alias_symbol
  hgnc_symbol: GIF
  entrez: '2694'
- word: TNM
  symbol: TNM
  source: hgnc_prev_symbol
  hgnc_symbol: TENM1
  entrez: '10178'
- word: (CEA)
  symbol: CEA
  source: hgnc_prev_symbol
  hgnc_symbol: CEACAM5
  entrez: '1048'
- word: Inf
  symbol: INF
  source: hgnc_alias_symbol
  hgnc_symbol: GIF
  entrez: '2694'
chemicals:
- word: cisplatin
  source: MESH
  identifier: D002945
diseases:
- word: Non-small-cell lung cancer
  source: MESH
  identifier: D002289
- word: NSCLC
  source: MESH
  identifier: D002289
- word: tumor
  source: MESH
  identifier: D009369
- word: Hepatocellular carcinoma
  source: MESH
  identifier: D006528
- word: Glioma
  source: MESH
  identifier: D005910
- word: Colorectal cancer
  source: MESH
  identifier: D015179
- word: Breast cancer
  source: MESH
  identifier: D001943
---
